Tosi M, Catteruccia M, Cherchi C, Mizzoni I, D’Amico A. Switching therapies: safety profile of Onasemnogene abeparvovec-xioi in a SMA1 patient previously treated with Risdiplam. Acta Myol [Internet]. 2022 Sep. 30 [cited 2024 Apr. 25];41(3):117-20. Available from: https://www.actamyologica.it/article/view/127